Showing results (841-850 of 957) with videos related to

Sort By:
Pageof 96
Plos Neglected Tropical Diseases|April 30, 2021
"Kankasha" in Kassala: A prospective observational cohort study of the clinical characteristics, epidemiology, genetic origin, and chronic impact of the 2018 epidemic of Chikungunya virus infection in Kassala, SudanHilary Bower, Mubarak El Karsany, Abd Alhadi Adam Hussein Adam, et al.
Emerging Infectious Diseases|May 2, 2025
Diagnostic Accuracy of 3 Mpox Lateral Flow Assays for Antigen Detection, Democratic Republic of the Congo and United KingdomElie Ishara-Nshombo, Anushri Somasundaran, Alessandra Romero-Ramirez, et al.
Msphere|September 2, 2017
Deep Sequencing of RNA from Blood and Oral Swab Samples Reveals the Presence of Nucleic Acid from a Number of Pathogens in Patients with Acute Ebola Virus Disease and Is Consistent with Bacterial Translocation across the GutMiles W Carroll, Sam Haldenby, Natasha Y Rickett, et al.
Emerging Infectious Diseases|February 9, 2026
Multiplex PCR to Differentiate Monkeypox Virus CladesChristopher T Williams, Alessandra Romero-Ramirez, Adeleye Adesola Semiu, et al.
Critical Care (London, England)|July 30, 2016
Ebola virus disease and critical illnessAleksandra Leligdowicz, William A Fischer, Timothy M Uyeki, et al.
Clinical Pharmacology and Therapeutics|March 18, 2026
Optimal Dose and Safety of Intravenous Favipiravir in Hospitalized Patients With COVID-19: A Dose-Escalating, Randomized Controlled Phase Ib StudyTim Rowland, Richard FitzGerald, Elizabeth Challenger, et al.
Morbidity and Mortality Weekly Report. Surveillance Summaries (Washington, D.C. : 2002)|January 17, 2003
Adult blood lead epidemiology and surveillance--United States, 1998-2001Robert J Roscoe, Wayne Ball, John J Curran, et al.
Clinical Pharmacology and Therapeutics|October 26, 2021
An Open Label, Adaptive, Phase 1 Trial of High-Dose Oral Nitazoxanide in Healthy Volunteers: An Antiviral Candidate for SARS-CoV-2Lauren E Walker, Richard FitzGerald, Geoffrey Saunders, et al.
Molecular Cancer|March 23, 2022
A non-coding RNA balancing act: miR-346-induced DNA damage is limited by the long non-coding RNA NORAD in prostate cancerC E Fletcher, L Deng, F Orafidiya, et al.
Ophthalmology|July 18, 2017
Prevalence of Age-Related Macular Degeneration in Europe: The Past and the FutureJohanna M Colijn, Gabriëlle H S Buitendijk, Elena Prokofyeva, et al.
Pageof 96